申请人:STERLING DRUG INC.
公开号:EP0392160A1
公开(公告)日:1990-10-17
N-[(alkylamino)alkyl]-4,5-diaryl-1H-imidazole-1-acetamides of formula
or acid-addition salt thereof wherein R¹ and R² are independently hydrogen, hydroxy, lower-alkyl, lower-alkoxy, nitro, or halo; R³ and R⁴ are independently hydrogen, lower-alkyl, or hydroxy lower-alkyl, or R³ and R⁴ together form a straight or branched alkylene chain of four to six carbons; A is CH₂CH(OH)CH₂ or (CH₂)n wherein n is an integer from two to eight, useful for treating cardiac arrhythmias in mammals, are prepared by reacting a lower-alkyl ester of a diaryl imidazole-1-acetic acid with an appropriate diamine.
式中的 N-[(烷基氨基)烷基]-4,5-二基-1H-咪唑-1-乙酰胺
或其酸加成盐 其中 R¹ 和 R² 独立地为氢、羟基、低级烷基、低级烷氧基、硝基或卤代;R³ 和 R⁴ 独立地为氢、低级烷基或羟基低级烷基,或 R³ 和 R⁴ 共同形成四至六个碳原子的直链或支链亚烷基链;A 是 CH₂CH(OH)CH₂或 (CH₂)n,其中 n 是 2 到 8 的整数,可用于治疗哺乳动物的心律失常,其制备方法是将二芳基咪唑-1-乙酸的低级烷基酯与适当的二胺反应。